Korea University Cancer Institute

Ä¿¹Â´ÏƼ

°øÁö»çÇ×

HOME > Ä¿¹Â´ÏƼ > °øÁö»çÇ×
Á¦¸ñ 2020Ò´ 5êÅ °í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ¼¼¹Ì³ª ¾È³»[¾È¾Ï]-5¿ù 12ÀÏ
±Û¾´ÀÌ °ü¸®ÀÚ ÀÛ¼ºÀÏ 2020-04-28 11:51:26
À̸ÞÀÏ
kuho@kumc.or.kr
¼öÁ¤ÀÏ
2020-04-29 11:56:19

°í·Á´ëÇб³ ¾Ï ¿¬±¸¼Ò(http://www.kucancer.org)°¡ ÁÖÃÖÇÏ´Â 2020³â 5¿ù ¼¼¹Ì³ª´Â ¿Â¶óÀÎÀ¸·Î ÁøÇàµË´Ï´Ù.


* ÀϽà : 2020³â 5¿ù 12ÀÏ (È­) ³· 12½Ã 30ºÐ
* ¹æ½Ä : Google Meet ¿Â¶óÀÎ ¼¼¹Ì³ª (¸µÅ©: meet.google.com/jvh-keze-evn )
* ¿¬ÀÚ : ±Ç Åà ±Ô ±³¼ö´Ô
* ¼Ò¼Ó : °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ¸é¿ªÇб³½Ç
* ÁÖÁ¦ : Inhibition of cathepsin K overcomes anti-cancer drug resistance via disruption of OTUB1-mediated Raptor stabilization.


1. ¿ÀÇÁ¶óÀÎ Âü¼®À» ¿øÇϽô °æ¿ì À̸ÞÀÏ¿¡ ´äÀåÀ¸·Î ¿¬¶ô. (ÀÇ°ú´ëÇÐ º»°ü 418È£)
2. ÃÖ±Ù ÇØ¿Ü¿©Çà·Â, ÃÖ±Ù ÀÚ°¡°Ý¸® ´ë»ó ¿©ºÎ¸¦ ¸í½ÃÇØ ÁֽʽÿÀ.
3. ¹ß¿­°Ë»ç, °­Àǽdz» 2¹ÌÅÍ ÀÌ»ó °Å¸® À¯Áö ¹× ¸¶½ºÅ© »ó½Ã Âø¿ë¿¡ µ¿ÀÇ (¸¶½ºÅ© º»ÀÎ ÁöÂü)
4. Á¡½É/Ä¿ÇÇ µî Á¦°ø ¾øÀ½. Èñ¸ÁÀÚ°¡ ¸¹À» °æ¿ì Âü¼® Àοø Á¦ÇÑ (¼±Âø¼ø)







ÀÌÀü±Û Á¾¾çÇ÷¾×³»°ú Supportive care ÄÉÀ̽º ¹ßÇ¥ ¹× ÅäÀÇ °øÁö - 4/28(È­)
´ÙÀ½±Û Á¾¾çÇ÷¾×³»°ú Supportive care ÄÉÀ̽º ¹ßÇ¥ ¹× ÅäÀÇ °øÁö - 5/12(È­)

ADD : ¿ì) 08308 ¼­¿ï½Ã ±¸·Î±¸ ±¸·Îµ¿·Î 148 °í·Á´ëÇб³ ºÎ¼Óº´¿ø ¾Ï ¿¬±¸¼Ò
Copyright by GnGlobal All Rights Reserved.